Experience in using ceretone (choline alfoscerate) in brain concussion
Nootropics are used to treat patients who have sustained concussion of the brain and complain of reductions in memory and working capacity, as well as emotional disorders. The efficacy of ceretone® (choline alfoscerate) was studied in 76 patients (45 men and 31 women whose age was 21-56 years) who h...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2010-12-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/306 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850188194238169088 |
|---|---|
| author | N. G. Voropay O. B. Doronina B. M. Doronin |
| author_facet | N. G. Voropay O. B. Doronina B. M. Doronin |
| author_sort | N. G. Voropay |
| collection | DOAJ |
| description | Nootropics are used to treat patients who have sustained concussion of the brain and complain of reductions in memory and working capacity, as well as emotional disorders. The efficacy of ceretone® (choline alfoscerate) was studied in 76 patients (45 men and 31 women whose age was 21-56 years) who had sustained brain concussion and had complaints of headache, easy fatigability, nocturnal sleep disorders, daytime sleepiness, anxiety, and bad mood. Thirty-nine patients received intravenous ceretone® in a dose of 1000 mg/day for 10 days; the other 37 patients formed a control group. A one-year follow-up indicated that ceretone® had a positive effect on health, autonomic, and emotional status and working capacity. |
| format | Article |
| id | doaj-art-59f5d871b21a4e7ea0e8a4d7cb08c0ec |
| institution | OA Journals |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| publishDate | 2010-12-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj-art-59f5d871b21a4e7ea0e8a4d7cb08c0ec2025-08-20T02:15:58ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422010-12-0124768010.14412/2074-2711-2010-122306Experience in using ceretone (choline alfoscerate) in brain concussionN. G. Voropay0O. B. Doronina1B. M. Doronin2Sibneuromed City Neurological Center, Novosibirsk State Medical UniversitySibneuromed City Neurological Center, Novosibirsk State Medical UniversitySibneuromed City Neurological Center, Novosibirsk State Medical UniversityNootropics are used to treat patients who have sustained concussion of the brain and complain of reductions in memory and working capacity, as well as emotional disorders. The efficacy of ceretone® (choline alfoscerate) was studied in 76 patients (45 men and 31 women whose age was 21-56 years) who had sustained brain concussion and had complaints of headache, easy fatigability, nocturnal sleep disorders, daytime sleepiness, anxiety, and bad mood. Thirty-nine patients received intravenous ceretone® in a dose of 1000 mg/day for 10 days; the other 37 patients formed a control group. A one-year follow-up indicated that ceretone® had a positive effect on health, autonomic, and emotional status and working capacity.https://nnp.ima-press.net/nnp/article/view/306brain concussionceretone (choline alfoscerate) |
| spellingShingle | N. G. Voropay O. B. Doronina B. M. Doronin Experience in using ceretone (choline alfoscerate) in brain concussion Неврология, нейропсихиатрия, психосоматика brain concussion ceretone (choline alfoscerate) |
| title | Experience in using ceretone (choline alfoscerate) in brain concussion |
| title_full | Experience in using ceretone (choline alfoscerate) in brain concussion |
| title_fullStr | Experience in using ceretone (choline alfoscerate) in brain concussion |
| title_full_unstemmed | Experience in using ceretone (choline alfoscerate) in brain concussion |
| title_short | Experience in using ceretone (choline alfoscerate) in brain concussion |
| title_sort | experience in using ceretone choline alfoscerate in brain concussion |
| topic | brain concussion ceretone (choline alfoscerate) |
| url | https://nnp.ima-press.net/nnp/article/view/306 |
| work_keys_str_mv | AT ngvoropay experienceinusingceretonecholinealfoscerateinbrainconcussion AT obdoronina experienceinusingceretonecholinealfoscerateinbrainconcussion AT bmdoronin experienceinusingceretonecholinealfoscerateinbrainconcussion |